Amgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several pa
Eli Lilly And Co (NYSE: LLY) shares are trading higher in the premarket session Wednesday after it announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study of